Villard, A., Goïta, A., Fillet, M., & Gilles, C. (27 October 2023). TF/FVIIa-mediated shedding of CD44 in EMT-shifted human breast tumor cells [Poster presentation]. BACR 2023, Bruxelles, Belgium. |
Villard, A., Özsoy, B., Fillet, M., & Gilles, C. (07 November 2022). TF/FVIIa-mediated shedding of CD44 in EMT-shifted human breast tumor cells [Poster presentation]. TEMTIA X Congress, Paris, France. |
Villard, A., Özsoy, B., Fillet, M., & Gilles, C. (07 November 2022). TF/FVIIa-mediated shedding of CD44 in EMT-shifted human breast tumor cells [Paper presentation]. TEMTIA X Congress, Paris, France. |
Villard, A., Genna, A., Lambert, J., Volpert, M., Noël, A., Hollier, B., Polette, M., Vanwynsberghe, A., & Gilles, C. (July 2022). Regulation of Tissue Factor by CD44 supports coagulant activity in breast tumor cells. Cancers, 14 (3288). doi:10.3390/cancers14133288 |
Villard, A., Genna, A., Vanwynsberghe, A., & Gilles, C. (20 June 2022). CD44 regulation of Tissue Factor-dependent procoagulant properties: implication for metastasis of breast tumor cells [Poster presentation]. European Association for Cancer Research, Séville, Spain. |
Villard, A., Genna, A., & Gilles, C. (08 April 2022). Regulation of tissue factor dependent procoagulant properties by CD44: Implication for metastasis of breast tumor cells [Poster presentation]. American Association for Cancer Annual Meeting 2022 (Virtual Congress), New Orleans (Virtual), United States. |
Villard, A., Genna, A., & Gilles, C. (28 January 2022). An EMT/CD44/TF axis in Circulating Tumour Cells [Poster presentation]. Séminaire Télévie 2022, Liège, Belgium. |
Villard, A., Verbinnen, L., Genna, A., Özsoy, B., & Gilles, C. (14 December 2021). CD44 and Tissue Factor protein interaction: implication for metastasis of breast tumor cells [Poster presentation]. GIGA-CANCER DAY 2021, Liège, Belgium. |
Villard, A., Verbinnen, L., Genna, A., Özsoy, B., & Gilles, C. (14 December 2021). CD44 and Tissue Factor protein interaction: implication for metastasis of breast tumor cells [Paper presentation]. GIGA-CANCER DAY 2021. |
Villard, A., Genna, A., Vanwynsberghe, A., & Gilles, C. (09 June 2021). CD44 regulation of Tissue Factor-dependent procoagulant properties: implication for metastasis of breast tumor cells [Poster presentation]. European Association for Cancer Research Virtual Congress. |
Thibault, B.* , Ramos-Delgado, F.* , Pons-Tostivint, E.* , Therville, N., Cintas, C., Arcucci, S., Cassant-Sourdy, S., Reyes-Castellanos, G., Tosolini, M., Villard, A., Cayron, C., Baer, R., Bertrand-Michel, Pagan, D., Ferreira Da Mota, D., Yan, H., Falcomata, C., Muscari, F., Bournet, B., ... Guillermet-Guibert, J. (2021). Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. EMBO Molecular Medicine. doi:10.15252/emmm.202013502 * These authors have contributed equally to this work. |
Villard, A., Vanwynsberghe, A., Genna, A., & Gilles, C. (26 January 2021). An EMT/CD44/TF axis in Circulating Tumour Cells [Poster presentation]. Televie Cancer Seminar. |
Genna, A.* , Vanwynsberghe, A.* , Villard, A.* , POTTIER, C., Ancel, J., Polette, M., & Gilles, C. (2020). EMT-Associated Heterogeneity in Circulating Tumor Cells : Sticky Friends on the Road to Metastasis. Cancers, 12 (6), 1632. doi:10.3390/cancers12061632 * These authors have contributed equally to this work. |
Villard, A. (2018). Influence de la protéine Pumilio 2 sur le phénotype sénescent induit par les oncogènes [Master’s dissertation, UNamur - Université de Namur]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/248194 |
Villard, A. (2018). Rôle de PI3Kα dans la formation du stroma environnant [Master’s dissertation, UNamur - Université de Namur]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/248199 |